Datang Pharmaceutical: Net loss of 82.424 million yuan in 2025.

Dah Tang Pharmaceutical announcement, the company is expected to achieve operating income of 133 million yuan, a year-on-year decrease of 35.69%; the net profit attributable to the shareholders of the listed company is -82.424 million yuan, a year-on-year decrease of 882.27%; the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses is -88.393 million yuan, a year-on-year decrease of 8,108.84%; basic earnings per share is -0.32 yuan, a year-on-year decrease of 900.00%.